ZBH · Zimmer Biomet Holdings, Inc.

Healthcare NYQ United States zimmerbiomet.com ↗
Val Gro Qua Mom Sta Cap P/S2.10 P/E Fwd P/E10.31 PEG0.58 52W –  RSI Target$107.57 (+15.1%) Beta0.47 Div1.04%
Loading chart…
RSI ()
Pattern Overlays
Loading patterns…
Medical Devices Warsaw, United States 17,000 employees
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, healthcare institutions, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. It also offers ROSA Robot, which utilizes robotic technologies to assist a surgeon with implant positioning in total knee arthroplasty or partial knee arthroplasty; and the ZBEdge Platform connects robotic and digital technologies together to collect data before, during and after surgery, that can deliver insights to surgeons to assist in making informed decisions on patient care. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Signal
Trend Strength
Price Levels
52-Week Range
52W Low 52W High
Position in Range
RSI (14)
0 · Oversold RSI 40 Overbought · 100
Signal Neutral
EMA Price Levels
Activity & Patterns
Volume Analysis
Momentum Dashboard
Detected Patterns
8Bullish
5Bearish
0Neutral

Key Signals 4

▲ Double Bottom Major reversal 2026-07-13 · $93.34
Two lows ~$84.75 — bullish reversal confirmed
Learn more →
▲ Inv. Head & Shoulders Major reversal 2026-07-28 · $94.41
Inv. H&S neckline ~$94.41 broken — major bullish reversal
Learn more →
▼ Double Top Major reversal 2026-07-01 · $85.78
Two peaks ~$91.80 — bearish reversal confirmed
Learn more →
▼ Double Top Major reversal 2026-09-08 · $94.28
Two peaks ~$101.96 — bearish reversal confirmed
Learn more →

Momentum Signals 9

▲ MACD Bullish Crossover 2026-05-15 · $83.48
▲ Bull Flag 2026-06-24 · $90.26
▲ MACD Bullish Crossover 2026-07-10 · $91.34
▲ Bull Flag 2026-07-28 · $93.71

View overlays on the price chart via Overview tab → Pattern Overlays.

Next Earnings Nov 05, 2026
Beat Rate 100%
Consensus BUY
Analyst Upside +15.1%
EPS — History & Forecast
Estimate Beat Miss Forecast
Loading…
Revenue — History & Forecast
Revenue Forecast
Loading…
EPS Beat Rate
100% 8/8 quarters
Wall Street Consensus
BUY
9
18
BuyHoldSell
Price Target Range
$107.57 +15.1% upside
Low $93 High $130
Consensus Current price
Wall Street Analyst Ratings
Sort by
Firm Rating Change Action Date
Profitability
Gross Margin 69.88%Last 12 Months
Operating Margin 17.96%Last 12 Months
Return on Equity 6.41%Last 12 Months
Revenue Growth 4.80%Year over Year
Free Cash Flow 1.09BLast 12 Months
Free Cash Flow Yield Last 12 Months
Balance Sheet
Debt / Equity 60.17Most Recent Quarter
Current Ratio 1.69Most Recent Quarter
Cash 464.50MMost Recent Quarter
Total Debt 7.60BMost Recent Quarter
Net Debt Most Recent Quarter
How ZBH Makes Its Money
Cash Flow Breakdown
Quarterly Metrics
QuarterRevenueRev YoYGross Profit Op. IncomeNet IncomeNet YoY Gross %Op %Net %
Full Key Statistics
Valuation
Market Cap17.83B
Enterprise Value24.98B
Trailing P/E22.42
Forward P/E10.31
PEG Ratio (5yr)0.58
Price/Sales (ttm)2.10
Price/Book (mrq)1.41
EV/Revenue2.94
EV/EBITDA9.78
Share Statistics
Avg Vol (3m)2.21M
Shares Outstanding190.74M
Float190.12M
% Held by Insiders0.16%
% Held by Institutions111.36%
Short Ratio4.06
Short % of Float6.08%
Profitability
Gross Margin69.88%
Operating Margin (ttm)17.96%
Profit Margin9.48%
Return on Assets (ttm)3.96%
Return on Equity (ttm)6.41%
Income Statement
Revenue (ttm)8.51B
Revenue Growth (yoy)4.80%
Gross Profit (ttm)5.95B
EBITDA2.56B
Net Income (ttm)806.70M
Diluted EPS (ttm)4.17
EPS Growth (yoy)33.80%
Balance Sheet
Total Cash (mrq)464.50M
Total Debt (mrq)7.60B
Debt / Equity (mrq)60.17
Current Ratio (mrq)1.69
Book Value / Share66.23
Operating CF (ttm)1.74B
Free Cash Flow (ttm)1.09B
Trading & Dividends
Beta (5Y)0.47
50-Day MA95.15
200-Day MA91.43
Fwd Dividend Yield1.04%
Payout Ratio23.30%
Income
Dividend Yield 1.04%Last 12 Months
Annual Rate 0.96Forward
Payout Ratio 23.30%Last 12 Months
Dividend History
Payout Ratio (Last 12 Months): 23.30%
Monthly Dividends
Ownership Breakdown
Institutional 111.36% Insider 0.16%
Short Interest 6.08% of float
Moderate
Institutional 13F Holdings

Famous investors who disclosed a position in ZBH in their latest SEC 13F filing.

Loading…
Insider Transactions
Date Insider Role Transaction Shares Price Value